Literature DB >> 25882190

Gephyrin: a central GABAergic synapse organizer.

Gayoung Choii1, Jaewon Ko2.   

Abstract

Gephyrin is a central element that anchors, clusters and stabilizes glycine and γ-aminobutyric acid type A receptors at inhibitory synapses of the mammalian brain. It self-assembles into a hexagonal lattice and interacts with various inhibitory synaptic proteins. Intriguingly, the clustering of gephyrin, which is regulated by multiple posttranslational modifications, is critical for inhibitory synapse formation and function. In this review, we summarize the basic properties of gephyrin and describe recent findings regarding its roles in inhibitory synapse formation, function and plasticity. We will also discuss the implications for the pathophysiology of brain disorders and raise the remaining open questions in this field.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25882190     DOI: 10.1038/emm.2015.5

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  51 in total

1.  Sleep-Dependent Structural Synaptic Plasticity of Inhibitory Synapses in the Dendrites of Hypocretin/Orexin Neurons.

Authors:  Idan Elbaz; David Zada; Adi Tovin; Tslil Braun; Tali Lerer-Goldshtein; Gordon Wang; Philippe Mourrain; Lior Appelbaum
Journal:  Mol Neurobiol       Date:  2016-10-12       Impact factor: 5.590

2.  De novo sequencing and initial annotation of the Mongolian gerbil (Meriones unguiculatus) genome.

Authors:  Diego A R Zorio; Scott Monsma; Dan H Sanes; Nace L Golding; Edwin W Rubel; Yuan Wang
Journal:  Genomics       Date:  2018-03-08       Impact factor: 5.736

Review 3.  Inhibitory neurotransmission regulates vagal efferent activity and gastric motility.

Authors:  Caitlin A McMenamin; R Alberto Travagli; Kirsteen N Browning
Journal:  Exp Biol Med (Maywood)       Date:  2016-06

4.  Altered brain activity during withdrawal from chronic alcohol is associated with changes in IL-6 signal transduction and GABAergic mechanisms in transgenic mice with increased astrocyte expression of IL-6.

Authors:  Donna L Gruol; Salvador Huitron-Resendiz; Amanda J Roberts
Journal:  Neuropharmacology       Date:  2018-05-19       Impact factor: 5.250

5.  CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.

Authors:  Alexey M Petrov; Morrie Lam; Natalia Mast; Jean Moon; Yong Li; Erin Maxfield; Irina A Pikuleva
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

6.  Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.

Authors:  Ciria C Hernandez; Wenshu XiangWei; Ningning Hu; Dingding Shen; Wangzhen Shen; Andre H Lagrange; Yujia Zhang; Lifang Dai; Changhong Ding; Zhaohui Sun; Jiasheng Hu; Hongmin Zhu; Yuwu Jiang; Robert L Macdonald
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

7.  Cocaine Dysregulates Dynorphin Modulation of Inhibitory Neurotransmission in the Ventral Pallidum in a Cell-Type-Specific Manner.

Authors:  Kineret Inbar; Liran A Levi; Nimrod Bernat; Tal Odesser; Dorrit Inbar; Yonatan M Kupchik
Journal:  J Neurosci       Date:  2019-12-13       Impact factor: 6.167

8.  Investigating the Mechanism by Which Gain-of-function Mutations to the α1 Glycine Receptor Cause Hyperekplexia.

Authors:  Yan Zhang; Anna Bode; Bindi Nguyen; Angelo Keramidas; Joseph W Lynch
Journal:  J Biol Chem       Date:  2016-05-18       Impact factor: 5.157

9.  IQ Motif and SEC7 Domain-containing Protein 3 (IQSEC3) Interacts with Gephyrin to Promote Inhibitory Synapse Formation.

Authors:  Ji Won Um; Gayoung Choii; Dongseok Park; Dongwook Kim; Sangmin Jeon; Hyeyeon Kang; Takuma Mori; Theofilos Papadopoulos; Taesun Yoo; Yeunkum Lee; Eunjoon Kim; Katsuhiko Tabuchi; Jaewon Ko
Journal:  J Biol Chem       Date:  2016-03-21       Impact factor: 5.157

Review 10.  The microtubule cytoskeleton at the synapse.

Authors:  Julie Parato; Francesca Bartolini
Journal:  Neurosci Lett       Date:  2021-03-26       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.